As with RPL3, deregulated RPS4X has been previously associated with various tumors and tumor phenotypes, including subgroups of colorectal carcinoma, a myelodysplasia risk signature and poor prognosis in bladder cancer [15, 18, 41]. This evidence concerns the gene RPL3 and urinary bladder cancer.